Quan Vu - 02 Dec 2025 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Signature
/s/ Quan Vu
Issuer symbol
MNPR
Transactions as of
02 Dec 2025
Transactions value $
$0
Form type
4
Filing time
08 Dec 2025, 16:47:01 UTC
Previous filing
05 Mar 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Vu Quan Anh Chief Financial Officer 1000 SKOKIE BLVD SUITE 350, WILMETTE /s/ Quan Vu 08 Dec 2025 0001892297

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Stock Options Award $0 +7.14K $0.00 7.14K 02 Dec 2025 Common Stock 7.14K $75.94 Direct F1
transaction MNPR Restricted Stock Units Award $0 +9.83K $0.00 9.83K 02 Dec 2025 Common Stock 9.83K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest 6/48ths on June 30, 2026, and 1/48th per month thereafter.
F2 RSUs vest 6/48ths on June 30, 2026, and 3/48ths per quarter thereafter.